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Editorial on the Research Topic
Celebrating Twenty Years of the Brazilian Symposium on Cardiovascular Physiology
This research topic is dedicated to the celebration of 20 years of the Brazilian Symposium
on Cardiovascular Physiology. In 1996 groups from the School of Medicine of Ribeirao Preto,
University of Sao Paulo (FMRP-USP) and from the Federal University of Sao Paulo (UNIFESP)
joined together to discuss cardiovascular physiology. In subsequent editions of the meeting, the
participation of other groups from all over the country has grown and acquired the status of a
national symposium. The participants now agree that the symposium should be itinerant and that
the chair group is responsible for its organization. In 2016, we proudly reached the 20th edition
of the Brazilian Symposium on Cardiovascular Physiology. It is certainly a memorable date and a
great opportunity to share the accomplishments of Brazilian groups in the field of cardiovascular
physiology.
The groups devoted to investigate cardiovascular physiology in Brazil descended, in a direct or
indirect manner, from the Argentinian physiologist and Nobel Prize winner Bernardo Houssay.
One of his disciples, Miguel Covian, was invited to be the chair of the Department of Physiology in
the School of Medicine of Ribeirao Preto when it was funded in the 1950’s. At the same time, the
physicians at Federal University of Rio Grande do Sul started a collaborative work with Bernardo
Houssay’s and BraunMenendez’s groups. That historical perspective is presented in this issue in the
article by Vasquez. In his paper, he also shares the contributions of Professor Eduardo M. Krieger
to the development of cardiovascular physiology in Brazil.
The etiology of cardiovascular and metabolic diseases reveals the involvement of different
genetic, environmental, nutritional and behavioral aspects. In this issue, Costa-Silva et al. discuss
the role of maternal diet on the development of cardiometabolic diseases. The authors point out
that epigenetic alterations can be, at least in part, responsible for the increased risk of developing
cardiometabolic problems. The authors discuss in detail the manner in which maternal protein
undernutrition or overnutrition during the perinatal period can increase the risk of cardiovascular
and metabolic diseases.
It is important to highlight that the success of the experimental design for investigating
cardiovascular physiology depends on the availability of suitable experimental models. In this
context, Crestani reviews the effects of acute and chronic emotional stress in cardiovascular
function. The author focused on the cardiovascular responses observed in different animal models
of emotional stress. Considering the impact of stress in the cardiovascular system in humans, this
is certainly a promising area of research.
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The influence of the autonomic nervous system in
cardiovascular function is remarkable. Thus, different research
groups in Brazil are devoted to investigating such influence
in health and disease. In the present issue, Accorsi-Mendonça
et al. present a historical retrospective on the characteristics of
rostral ventrolateral medulla (RVLM) presympathetic neurons
and discuss the concept that those cells work as pacemakers for
the generation of the sympathetic activity. Interestingly, physical
activity can modulate central areas involved in autonomic
control of the cardiovascular system. In this context, Raquel et al.
show that swimming modulates nitric oxide (NO) availability
and glutamatergic neurotransmission in the RVLM, contributing
to a decrease in sympathetic activity and an increase in baroreflex
control of blood pressure (BP). This provides insight and support
to the idea that physical activity should be included when treating
hypertensive patients.
Pharmacological modulation of the autonomic nervous
system is an important target to treat cardiovascular diseases
(CVD). Alternative experimental approaches in this field include
the search for new natural and synthetic compounds. In this
regard, Pinto et al. observed that bombesin, a peptide isolated
from frog skin, increases blood pressure and renal sympathetic
nerve activity (RSNA) when administered into the RVLM of
normotensive and spontaneously hypertensive rats (SHR). In
addition, Silva et al. show that ivabradine reduced resting heart
rate and blood pressure, with no effects on cardiovascular reflexes
or RSNA.
Other important group of neurons involved in autonomic
cardiovascular control are present in the paraventricular nucleus
of the hypothalamus (PVN). This region possesses reciprocal
communications with the nucleus tractus solitarii (NTS) and
synapses with both the RVLM itself and the subfornical organ
(SFO), which receives information from directly from the
blood stream since it lacks a blood brain barrier. In this
context, De Melo et al. hypothesize that the decrease in ovarian
hormones during menopause blunts oxytocin expression and
signaling in pre-autonomic PVN neurons, leading to baroreflex
impairment, autonomic imbalance and arterial hypertension.
This reinforces clinical findings that women are more prone
to develop CVD after menopause than men of the same age
and provides experimental data to further support hormonal
reposition therapies.
Considering that an increase in blood pressure variability
(BPV) is an indicative of poor prognosis in cardiovascular
outcomes, Freitas et al. demonstrate that increased BPV prior
to the onset of chronic kidney disease can reduce renal blood
flow, increase renal vascular resistance and increase uraemia
and glomerulosclerosis, exacerbating renal dysfunction. In this
scenario, the authors suggest that increased BPV may be
considered as a marker for target-organ damage.
Recently, the gut microbiota has gained attention as it can
be involved in the onset of diverse pathological states, including
the development of CVD. In this context, de Brito-Alves et al.
show evidence, from both experimental and clinical approaches,
that the use of polyphenols and probiotics reduces blood
pressure and improves cardiovascular function. In agreement
with this, Klippel et al. present an experimental study in which
the administration of kefir (a probiotic composed by different
bacteria such as Lactobacillus kefiranofaciens, Lactobacillus kefir,
and Candida kefir) to SHR resulted in the amelioration of
vagal and sympathetic imbalance, improvement of baroreflex
sensitivity and a reduction in blood pressure. Taken together,
these reports emphasize the potential of probiotics as adjuvants
on CVD treatment.
Despite the fundamental role played by the central nervous
system (CNS) in cardiovascular control, the peripheral control
of blood flow to target organs in response to specific organ
demands presents an important role in BP homeostasis. This
is particularly evident during sepsis and septic shock, when a
massive vasodilation causes a remarkable reduction in blood
pressure, with a high mortality rate. During this state, there
is also a vascular hyporesponsivity to vasoconstrictors, limiting
therapeutic options. Thus, Pernomian et al. used an experimental
model of sepsis to evaluate the participation of C-type natriuretic
peptide on this response. The authors suggest that this peptide is
involved in hyporeactivity to vasoconstrictors in aorta, revealing
a novel potential target for septic shock.
In the present issue, Costa et al. provide a relevant review on
the vascular effects of neuronal nitric oxide synthase (nNOS).
It is important to highlight that, although endothelial NOS
(eNOS) is considered the main NOS isoform in vessels, nNOS
is an important source of both NO and hydrogen peroxide
(H2O2), two endothelium-dependent vasodilators. Imbalances in
nNOS expression and/or activity have been described in arterial
hypertension and atherosclerosis, corroborating the idea that this
isoform is particularly relevant for proper vessel function. Nitric
oxide signaling can be modulated by physical activity not only
in the CNS as previously discussed but also in the periphery.
In this context, Macedo et al. evaluated the participation of
NO in vascular tone adjustments in response to low-intensity
resistance training. They observed increased expression of eNOS
and nNOS, culminating in an improvement of vascular function,
increase in baroreflex sensitivity and reduction in blood pressure.
Additionally, a further guardian of vascular homeostasis is
perivascular adipose tissue (PVAT), which can secrete vasoactive
substances. In this context, Victorio et al. comparatively
evaluated the effects of PVAT from abdominal and thoracic aorta.
The authors observed functional regional differences along the
aorta, with a greater production of vasodilators in thoracic vs.
abdominal PVAT.
Despite the efforts of diverse research groups in Brazil and
abroad, CVD still is the leading cause of death worldwide. The
efficient function of the cardiovascular system depends to a large
degree on good cardiac function, which may be impaired after
myocardial infarction (MI), for example. In this issue, Santana
et al. compare two different techniques to induce MI in rats.
Patterns of gene expression were seen to differ between the two
methods. This study certainly contributes to the standardization
of suitable experimental models that will allow new approaches
to prevent and treat MI. For instance, Manchini et al. used low-
level laser therapy to improve left ventricular systolic function.
Although the results are promising, the beneficial effects seem
to be transient and long-term studies are needed. Heart failure
is commonly observed after MI and this compromises not only
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the function of the heart per se but also leads to damage in
target organs. It was observed by Arruda-Junior et al. that
rats with heart failure presented impaired renal function (fluid
retention, reduction in glomerular filtration rate, increase in
protein excretion), which was preserved by the inhibition of
dipeptidyl peptidase IV. de Melo et al. provide us with another
example of beneficial outcomes from physical exercise. The
authors evaluated the effects of exercise training in a model
of right ventricular remodeling and found that it attenuated
myocardial remodeling and improved right ventricular function.
Different strategies to deal with CVD often come from the
discovery of new physiological pathways. In this context, Xu
et al. reviewed the role played by ADAM17 (A disintegrin A
metalloprotease 17) in the cardiovascular system as well as in
CNS areas involved in cardiovascular control. Although it is a
very promising target molecule, the diversity of its substrates
(this enzyme is involved with more than 70 different substrates)
including inflammatory substances, have slowed the progression
of translational studies.
As highlighted here, based on the quality of the different
studies presented, the initiative of creating the Brazilian
Symposium on Cardiovascular Physiology 20 years ago has
contributed enormously to the development of research on
cardiovascular physiology in Brazil. The country now holds more
than 20 different research groups established from the north
to the south of the country producing worldwide recognized
science. Most laboratories are well-equipped with cutting-edge
technology allowing in-deep investigations into cardiovascular
phenomena. The main limitations currently faced by Brazilian
researchers are the strict rules governing the importation of
research goods (such as chemicals, reagents, live animals,
viruses for gene transfer and general lab equipment) and the
uneven distribution of research funding across the country. In
conclusion, we would like to thank very much all the Brazilian
research groups who attended to the 20th Brazilian Symposium
on Cardiovascular Physiology and the reviewers who generously
agreed to review the manuscripts presented in this issue.
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